Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2015

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

Rishi P. Singh, MD

Show Description +

Rishi P. Singh, MD, of the Cleveland Clinic, discusses safety and efficacy data from a pair of phase 2 clinical trials evaluating RTH258 as a treatment for neovascular age-related macular degeneration.

Posted: 7/10/2015

Up Next

Complications Associated with PVR Surgery: New Approaches

Complications Associated with PVR Surgery: New Approaches

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Preview to the ASRS Annual Meeting in Vienna

Preview to the ASRS Annual Meeting in Vienna

Carl Regillo, MD, Jonathan L. Prenner, MD

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Intravitreal Injections: Do They Induce Trauma to the Lens?

Intravitreal Injections: Do They Induce Trauma to the Lens?

Paul Hahn, MD, PhD, Steven Yeh, MD

A Post Hoc Analysis of the RISE and RIDE Studies

A Post Hoc Analysis of the RISE and RIDE Studies

J. Michael Jumper, MD, Steven Yeh, MD

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Steven Yeh, MD, Kevin J. Blinder, MD

Back to All Videos

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

Rishi P. Singh, MD

Rishi P. Singh, MD, of the Cleveland Clinic, discusses safety and efficacy data from a pair of phase 2 clinical trials evaluating RTH258 as a treatment for neovascular age-related macular degeneration.

Posted: 7/10/2015

Please log in to leave a comment.

More From ASRS: 2015 Coverage

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2015.